Also trades as: 0Y6X.L (LSE) · $vol 1M · 2M6.DE (XETRA) · $vol 0M

$80.20

-0.13 (-0.16%)

Pre-Market: $80.25 (+0.05, +0.06%)

Weekly Expected Move ±5.0%

$73 $78 $82 $86 $90

NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 59 · $103.0B mcap · 1.28B float · 0.770% daily turnover · Short 36% of daily vol

Revenue

$36.4B +8.4% ▲

5Y CAGR: +3.8%

Gross Profit

$23.6B +7.9% ▲

5Y CAGR: +3.8%

Operating Income

$6.5B +8.6% ▲

5Y CAGR: +7.6%

Net Income

$4.8B +3.0% ▲

5Y CAGR: +5.9%

EPS (Diluted)

$3.73 +3.3% ▲

5Y CAGR: +7.0%

EBITDA

$6.9B -25.7% ▼

5Y CAGR: -1.9%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$31.7B	$31.2B	$32.4B	$33.5B	$36.4B
YoY Growth	+5.2%	-1.4%	+3.6%	+3.6%	+8.4%
Cost of Revenue	$10.1B	$10.7B	$11.2B	$11.6B	$12.7B
Gross Profit	$21.5B	$20.5B	$21.1B	$21.9B	$23.6B
Gross Margin	68.0%	65.7%	65.3%	65.3%	65.0%
R&D Expenses	$2.7B	$2.7B	$2.7B	$2.7B	$2.9B
SG&A Expenses	$10.3B	$10.4B	$10.7B	$10.8B	$11.8B
Operating Expenses	$15.8B	$15.0B	$16.0B	$15.9B	$17.2B
Operating Income	$5.8B	$5.5B	$5.1B	$6.0B	$6.5B
Operating Margin	18.2%	17.6%	15.9%	17.8%	17.8%
Interest Expense	$553M	$636M	$719M	$729M	$715M
Income Before Tax	$5.5B	$5.4B	$4.8B	$5.6B	$6.1B
Tax Expense	$456M	$1.6B	$1.1B	$936M	$1.3B
Net Income	$5.0B	$3.8B	$3.7B	$4.7B	$4.8B
Net Margin	15.9%	12.0%	11.4%	13.9%	13.2%
EPS (Diluted)	$3.73	$2.82	$2.76	$3.61	$3.73
EBITDA	$8.8B	$8.7B	$8.2B	$9.2B	$6.9B
Shares Outstanding	1.35B	1.33B	1.33B	1.29B	1.29B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$8.1B	$8.6B	$7.9B	$8.4B	$8.3B	$8.9B	$8.6B	$9.0B
Cost of Revenue	$2.8B	$3.0B	$2.8B	$2.9B	$2.8B	$3.1B	$3.6B	$3.6B
Gross Profit	$5.3B	$5.5B	$5.2B	$5.5B	$5.5B	$5.8B	$4.9B	$5.4B
Gross Margin	65.6%	64.6%	65.1%	64.9%	66.5%	64.7%	57.7%	60.3%
R&D Expenses	$695M	$675M	$676M	$697M	$675M	$684M	$726M	$754M
SG&A Expenses	$2.7B	$2.8B	$2.7B	$2.8B	$2.7B	$2.7B	$2.8B	$3.0B
Operating Expenses	$3.8B	$4.5B	$3.9B	$3.9B	$3.9B	$4.3B	$3.5B	$3.7B
Operating Income	$1.5B	$1.1B	$1.3B	$1.6B	$1.6B	$1.4B	$1.4B	$1.7B
Operating Margin	18.3%	12.3%	16.1%	19.0%	19.9%	16.1%	16.8%	18.8%
Interest Expense	$188M	$202M	$167M	$209M	$179M	$174M	$176M	$181M
Income Before Tax	$1.5B	$856M	$1.3B	$1.6B	$1.5B	$1.3B	$1.3B	$1.6B
Tax Expense	$135M	$197M	$220M	$281M	$237M	$199M	$255M	$215M
Net Income	$1.3B	$654M	$1.0B	$1.3B	$1.3B	$1.1B	$1.0B	$1.4B
Net Margin	16.3%	7.6%	13.2%	15.1%	15.6%	11.8%	12.1%	15.3%
EPS (Diluted)	$0.99	$0.49	$0.80	$0.99	$1.01	$0.82	$0.81	$1.07
EBITDA	$2.3B	$1.7B	$2.1B	$2.4B	$2.4B	$2.3B	$2.2B	$2.4B
Shares Outstanding	1.33B	1.33B	1.30B	1.29B	1.29B	1.29B	1.29B	1.29B

MDT NYSE